United Therapeutics buy Royal Bank of Canada
Start price
07.05.26
/
50%
€485.40
Target price
07.05.27
€596.27
Performance (%)
-5.03%
Price
21:36
€461.00
Summary
This prediction is currently active. With a performance of -5.03%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 07.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -1.693% | -1.693% |
| iShares Core DAX® | -3.173% | 1.229% |
| iShares Nasdaq 100 | -1.006% | 0.381% |
| iShares Nikkei 225® | -3.600% | 1.005% |
| iShares S&P 500 | 0.214% | 2.924% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (UTHR) had its price target lowered by Royal Bank Of Canada from $707.00 to $701.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€493.50
07.07.26
07.07.26
€615.51
07.07.27
07.07.27
-6.59%
21:36
21:36
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
7.99%
21:36
21:36
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
26.51%
21:36
21:36